OPOCRIN GROUP

What this means for you

Registered since 22 Aug 2023. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

79331046

Registration number

7141201

Mark type

Design + words

Filed

26 Nov 2021

Published for opposition

06 Jun 2023

Registered

22 Aug 2023

Attorney of record

Robert S. Broder

Goods and services

• Class 001 — Chemicals: Chemicals for use in the manufacture of pharmaceuticals; active chemical ingredients for use in the manufacture of pharmaceuticals for treating Respiratory Distress Syndrome (RDS) in premature infants, for preventing venous and arterial thrombosis and cardiovascular disease and for the treatment of iron deficiency anemia
• Class 005 — Pharmaceuticals: Chemical preparations for pharmaceutical or medical purposes, namely, for treating Respiratory Distress Syndrome (RDS) in premature infants, for preventing venous and arterial thrombosis and cardiovascular disease and for the treatment of iron deficiency anemia; enzymes for medical purposes

Owner

• OPOCRIN S.p.A., IT
• OPOCRIN S.p.A., IT
• OPOCRIN S.p.A., IT

Prosecution history

• 11 Dec 2023 — FINAL DECISION TRANSACTION PROCESSED BY IB
• 22 Nov 2023 — FINAL DISPOSITION NOTICE SENT TO IB
• 22 Nov 2023 — FINAL DISPOSITION PROCESSED
• 22 Nov 2023 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
• 22 Aug 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
• 22 Aug 2023 — REGISTERED-PRINCIPAL REGISTER
• 03 Jul 2023 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
• 19 Jun 2023 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
• 14 Jun 2023 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
• 06 Jun 2023 — NOTIFICATION PROCESSED BY IB
• 06 Jun 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 06 Jun 2023 — PUBLISHED FOR OPPOSITION
• 27 May 2023 — NEW REPRESENTATIVE AT IB RECEIVED
• 17 May 2023 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
• 17 May 2023 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB